A John Iafrate
Overview
Explore the profile of A John Iafrate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
271
Citations
32108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitsiades I, Onozato M, Iafrate A, Hicks D, Gulhan D, Sgroi D, et al.
Breast Cancer Res
. 2024 Dec;
26(1):185.
PMID: 39695741
Background: The HOXB13/IL17RB gene expression biomarker has been shown to predict response to adjuvant and extended endocrine therapy in patients with early-stage ER+ HER2- breast tumors. HOXB13 gene expression is...
2.
Roederer A, Cao Y, St Denis K, Sheehan M, Li C, Lam E, et al.
Cell Rep Med
. 2024 Dec;
5(12):101850.
PMID: 39657661
With the onset of the COVID-19 pandemic 4 years ago, viral sequencing continues to document numerous individual mutations in the viral spike protein across many variants. To determine the ability...
3.
Kaluziak S, Codd E, Purohit R, Melli B, Kalyan P, Fordham J, et al.
JCO Precis Oncol
. 2024 Dec;
8:e2400493.
PMID: 39637335
Purpose: The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) trial was implemented to identify actionable genetic alterations across cancer types and enroll patients accordingly onto treatment arms, irrespective of...
4.
Fisch A, Farahani A, Thierauf J, Iafrate A, Lennerz J, Faquin W
Head Neck Pathol
. 2024 Oct;
18(1):114.
PMID: 39460831
Purpose: MYB has been shown to play a central role in oncogenesis in a majority of adenoid cystic carcinomas (ACC). Testing for MYB expression via immunohistochemistry (IHC) or testing for...
5.
Bredella M, Fintelmann F, Iafrate A, Dagogo-Jack I, Dreyer K, Louis D, et al.
Radiology
. 2024 Jul;
312(1):e240335.
PMID: 39078305
No abstract available.
6.
Sabbagh M, Janovitz T, Dias-Santagata D, Siegmund S, Nardi V, Wirth L, et al.
Thyroid
. 2024 Jul;
34(9):1137-1149.
PMID: 39003525
Diagnostic classification of thyroid malignancy is primarily accomplished through examination of histomorphological features and may be substantiated and clarified by molecular data. Individual molecular drivers show relatively robust and specific...
7.
Xhori O, Deol N, Rivera C, Zavras J, Weil S, Zafari H, et al.
Head Neck Pathol
. 2024 Mar;
18(1):25.
PMID: 38526767
Objective: To review tumors identified as "clear cell sarcoma" in order to determine similarities to the rare EWS fusion positive jaw and salivary gland tumors clear cell odontogenic carcinoma (CCOC)...
8.
Roederer A, Cao Y, St Denis K, Sheehan M, Li C, Lam E, et al.
medRxiv
. 2024 Mar;
PMID: 38496628
Since the COVID-19 pandemic began in 2020, viral sequencing has documented 131 individual mutations in the viral spike protein across 48 named variants. To determine the ability of vaccine-mediated humoral...
9.
Das D, Hirayama S, Aye L, Bryan M, Naegele S, Zhao B, et al.
medRxiv
. 2024 Feb;
PMID: 38328243
Background: HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated cancer in the United States yet unlike cervical cancer lacks a screening test. HPV+OPSCCs are presumed to start developing 10-15...
10.
Zonozi R, Walters L, Shulkin A, Naranbhai V, Nithagon P, Sauvage G, et al.
Sci Transl Med
. 2023 Nov;
15(724):eadh4529.
PMID: 38019932
Individuals with primary and pharmacologic B cell deficiencies have high rates of severe disease and mortality from coronavirus disease 2019 (COVID-19), but the immune responses and clinical outcomes after severe...